author-photo

Yu Mizote

Okayama University

13

Papers

91

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.

2021 Immunotherapy
Show All
- Source
- Cite
- Save
Citations (3)
Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

2014 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (24)
TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).

2014 Journal of Dermatological Science
Show All
- Source
- Cite
- Save
Citations (2)
Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients.

2014 Vaccine
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 4732: Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)
Abstract 508: Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 518: Immunogenicity of cancer/testis antigen XAGE-1d in patients with non-small cell lung cancer (NSCLC)

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients

2012 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (28)